0001493152-24-052571.txt : 20241231 0001493152-24-052571.hdr.sgml : 20241231 20241230183813 ACCESSION NUMBER: 0001493152-24-052571 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241231 DATE AS OF CHANGE: 20241230 EFFECTIVENESS DATE: 20241231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001815974 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851170950 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-533737 FILM NUMBER: 241590817 BUSINESS ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 BUSINESS PHONE: 737 203 5270 MAIL ADDRESS: STREET 1: JFL CAPITAL MANAGEMENT STREET 2: 1017 RR 620 S, SUITE 107 CITY: LAKEWAY STATE: TX ZIP: 78734 D 1 primary_doc.xml X0708 D LIVE 0001815974 Anebulo Pharmaceuticals, Inc. 1017 RANCH ROAD 620 SOUTH SUITE 107 LAKEWAY TX TEXAS 78734 (512) 598-0931 DELAWARE None None Corporation true 2020 Richard Cunningham 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Executive Officer Director Daniel George 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Executive Officer Joseph F. Lawler 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Aron R. English 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Kenneth Lin 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Areta Kupchyk 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Bimal Shah 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Jason Aryeh 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Nathaniel Calloway 1017 Ranch Road 620 South Suite 107 Lakeway TX TEXAS 78734 Director Pharmaceuticals Decline to Disclose 06b false 2024-12-22 false true false 0 15000000 15000000 0 false 1 0 0 0 true While no offering proceeds are set aside for payments to the named officers or directors, it is possible that some proceeds to be used as working capital will be used indirectly for paying salaries to employees including executive officers false Anebulo Pharmaceuticals, Inc. /s/ Daniel George Daniel George Acting Chief Financial Officer 2024-12-30